search
Back to results

SEQUAR SEmitendinosus vs QUadriceps in Anterior Cruciate Ligament Reconstruction (SEQUAR)

Primary Purpose

Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture, Anterior Cruciate Ligament Tear

Status
Recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
ACL Reconstruction with Semitendinosus graft
ACL Reconstruction with Quadriceps tendon-bone graft
Sponsored by
Karolinska Institutet
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Anterior Cruciate Ligament Injuries

Eligibility Criteria

16 Years - 40 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Primary ACL reconstruction for patients with Tegner score equal or higher than 7 before injury.

Exclusion Criteria:

  • Multiligament knee injury
  • Former knee operation
  • Former fracture
  • Inflammatory disease
  • More than one ligamentous injury in the same knee requiring reconstructive surgery
  • Former ACL injury in the contralateral knee
  • Reconstruction of ACL in the contralateral knee during the study follow up period
  • Lack av baseline pre- or postoperative data (KT-1000, KOOS, Lysholm Score, EQ-5D)
  • Any other situation preventing patient from participating in extensive follow up.

Sites / Locations

  • Capio Artro Clinic ABRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Semitendinosus graft

Quadriceps tendon-bone graft

Arm Description

Participants receive the Semitendinosus Graft technique during ACL reconstruction.

Participants receive the Quadriceps Tendon-Bone Graft technique during ACL reconstruction.

Outcomes

Primary Outcome Measures

Change from Baseline KT-1000 Knee Laxity at 6 months
The KT-1000 measures laxity objective- and parametrically and is a validated tool for establishing joint laxity post operatively in mm.
Change from Baseline KOOS (the Knee Injury and Osteoarthritis Outcome Score) at 24 months
Patients will complete the KOOS surveys at pre-operatively and at 2 years time post-operatively to evaluate subjective knee function

Secondary Outcome Measures

IKDC
Patients will complete the IKDC at specific time points to evaluate subjective knee function throughout treatment.
PAS
Patients will complete the PAS at specific time points to evaluate subjective knee function throughout treatment
KOOS
Patients will complete the KOOS at specific time points to evaluate subjective knee function throughout treatment
EQ5D
Patients will complete the EQ5D at specific time points to evaluate subjective knee function throughout treatment
Lysholm score
Patients will complete the Lysholm score at specific time points to evaluate subjective knee function throughout treatment
Tegner Activity Score
Patients will complete the Tegner Activity score at specific time points to evaluate level of sports activity postoperatively.
ACL-RSI
Patients will complete the ACL-RSI surveys at specific time points to evaluate self efficacy and readiness to return to sports throughout treatment
Return to Sports Questionnaire
Patients will complete the a Return to Sports Questionnaire at specific time points to evaluate return to sports after 6 and 12 months throughout treatment
Werner anterior knee pain score
Patients will complete Werner anterior knee pain scores at specific time points to evaluate graft site pain/morbidity throughout treatment
Kartus anterior knee pain score
Patients will complete Kartus anterior knee pain score at specific time points to evaluate graft site pain/morbidity throughout treatment
Graft site morbidity questionnaire
Patients will complete additional survey questions at specific time points to evaluate graft site pain/morbidity throughout treatment
Goniometric measurement: Knee extension and flexion
Patients will undergo goniometric measurement at specific time points to evaluate knee moment throughout treatment.
Measurement of circumference of the knee
Circumference of the knee will be measured at mid-patella and 15 cm above superior border of the patella. They will be compared with the contralateral knee to compare knee swelling.
Biodex Isokinetic Measurement
Patients will undergo Biodex Isokinetic measurement at specific time points to muscle strength throughout treatment.
Functional knee tests
Patients will undergo functional knee test (ie one legged jump and crossover jump) at specific time points to evaluate functional knee movement throughout treatment.
Lachmans test
Patients will undergo passive accessory stability tests Lachmans test (graded 0,1,2 and 3) at specific time points to evaluate passive knee laxity throughout treatment.
Pivot shift test
Patients will undergo passive accessory stability tests pivot shift test (graded 0,1,2 and 3) at specific time points to evaluate passive knee laxity throughout treatment.
Time to Return to Sports Rates
Time to return to sports will be evaluated through Return to Sport surveys at specific time points throughout treatment
Graft failure rate or ACL re-rupture
ACL reconstruction will be evaluated by graft failure rate or ACL re-rupture during a 10 year period
ACL re-operation
ACL reconstruction will be evaluated by re-operation rate during a 10 year period
Graft maturity
Graft maturity after ACL reconstruction will be evaluated by MRI at 9 months postoperatively.
10 year X-Ray
Development of osteoarthritis after ACL reconstruction will be evaluated by plain weight baring X-rays at 10 years.

Full Information

First Posted
February 26, 2020
Last Updated
March 8, 2023
Sponsor
Karolinska Institutet
search

1. Study Identification

Unique Protocol Identification Number
NCT04295148
Brief Title
SEQUAR SEmitendinosus vs QUadriceps in Anterior Cruciate Ligament Reconstruction
Acronym
SEQUAR
Official Title
SEQUAR - SEmitendinosus vs QUadriceps in Anterior Cruciate Ligament Reconstruction - a Prospective Randomized Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 10, 2020 (Actual)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
December 31, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska Institutet

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Randomized control trial comparing two different Anterior Cruciate Ligament (ACL) grafts in Anterior Cruciate Ligament Reconstruction: the semitendinosus hamstrings graft and the quadriceps graft. Capio Artro Clinic (Stockholm) has vast experience in ACL surgery using both semitendinosus and quadriceps grafts.
Detailed Description
The purpose of the study is to evaluate the quadriceps graft with bone-plug in Anterior Cruciate Ligament Reconstruction (ACL-R) and compare it with Sweden's standard choice of graft, semitendinosus graft in ACL-R in higher level athletes with Tegner Activity Scale 7 or higher. Both methods are well-known and continually registered in the Swedish ACL Registry. Patients will be followed up during a 2-year period. Both grafts will be compared post operatively as to laxity, PROM, as well as measure graft site morbidity, Return to Sports rate, and the post-operative rehab. At 9 months we will also preform a MRI scan to determine graft maturity. 5-year and 10-year data will also be acquired through the Swedish ACL-registry and Lysholm score and Tegner Activity Level score. At 10-year a plain weight baring X-ray will be preformed to evaluate development of osteoarthritis.Both methods are well-known and continually registered in the Swedish ACL Registry. The study design is a prospective randomized study with equal groups: Semitendinosus graft (=100) and Quadriceps tendon graft (n=100). According to historical material from Capio Artro Clinic (Stockholm) the following power calculation has been made: Significance lever 5 percent (p=0.05) and power is 80%. The difference between the groups is 1 mm knee laxity with KT-1000 which would give an effect size of 0,44 or less compared to an average effect size (0,50). 85 individuals will be needed in each group in the statistical analysis. Stratifying according to gender will be done with 40% female and 60 % males, as this represent the prevalence of ACL reconstruction in our clinic and in the Swedish ACL registry. It is known the females have a higher rerupture rate and lower subjective outcome. Inclusion will continue until we have 100 individuals in each group according to the stratification. This means that each group can have more than 100 individuals. Randomization process and study design will be done according to the CONSORT guidelines.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture, Anterior Cruciate Ligament Tear

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Semitendinosus graft
Arm Type
Active Comparator
Arm Description
Participants receive the Semitendinosus Graft technique during ACL reconstruction.
Arm Title
Quadriceps tendon-bone graft
Arm Type
Active Comparator
Arm Description
Participants receive the Quadriceps Tendon-Bone Graft technique during ACL reconstruction.
Intervention Type
Procedure
Intervention Name(s)
ACL Reconstruction with Semitendinosus graft
Other Intervention Name(s)
ACL-R with Semitendinosus graft, Semitendinosus ACL-R
Intervention Description
Participants will undergo Anterior Cruciate Ligament Reconstruction with Semitendinosus graft
Intervention Type
Procedure
Intervention Name(s)
ACL Reconstruction with Quadriceps tendon-bone graft
Other Intervention Name(s)
ACL-R with Quadriceps tendon-bone graft, Quad tendon-bone ACL-R
Intervention Description
Participants will undergo Anterior Cruciate Ligament Reconstruction with Quadriceps tendon-bone graft
Primary Outcome Measure Information:
Title
Change from Baseline KT-1000 Knee Laxity at 6 months
Description
The KT-1000 measures laxity objective- and parametrically and is a validated tool for establishing joint laxity post operatively in mm.
Time Frame
Pre-operative appointment and 6 months post-operative appointments
Title
Change from Baseline KOOS (the Knee Injury and Osteoarthritis Outcome Score) at 24 months
Description
Patients will complete the KOOS surveys at pre-operatively and at 2 years time post-operatively to evaluate subjective knee function
Time Frame
Pre-operative appointment and 24 months
Secondary Outcome Measure Information:
Title
IKDC
Description
Patients will complete the IKDC at specific time points to evaluate subjective knee function throughout treatment.
Time Frame
Pre-operative appointment, 12 months, 24 months, 5 years and 10 years post-operative appointments
Title
PAS
Description
Patients will complete the PAS at specific time points to evaluate subjective knee function throughout treatment
Time Frame
Pre-operative appointment, 12 months, 24 months, 5 years and 10 years post-operative appointments
Title
KOOS
Description
Patients will complete the KOOS at specific time points to evaluate subjective knee function throughout treatment
Time Frame
Pre-operative appointment, 12 months, 24 months, 5 years and 10 years post-operative appointments
Title
EQ5D
Description
Patients will complete the EQ5D at specific time points to evaluate subjective knee function throughout treatment
Time Frame
Pre-operative appointment, 12 months, 24 months, 5 years and 10 years post-operative appointments
Title
Lysholm score
Description
Patients will complete the Lysholm score at specific time points to evaluate subjective knee function throughout treatment
Time Frame
Pre-operative appointment, 6 months, 9 months, 12 months, 18 months, 24 months, 5 years and 10 years post-operative appointments
Title
Tegner Activity Score
Description
Patients will complete the Tegner Activity score at specific time points to evaluate level of sports activity postoperatively.
Time Frame
Pre-operative appointment, 6 months, 9 months, 12 months, 18 months, 24 months, 5 years and 10 years post-operative appointments
Title
ACL-RSI
Description
Patients will complete the ACL-RSI surveys at specific time points to evaluate self efficacy and readiness to return to sports throughout treatment
Time Frame
6 months and 12 months, post-operative appointments
Title
Return to Sports Questionnaire
Description
Patients will complete the a Return to Sports Questionnaire at specific time points to evaluate return to sports after 6 and 12 months throughout treatment
Time Frame
6 months, 9 months and 12 months, 18 months, and 24 months post-operative appointments
Title
Werner anterior knee pain score
Description
Patients will complete Werner anterior knee pain scores at specific time points to evaluate graft site pain/morbidity throughout treatment
Time Frame
6 weeks, 6 months, 9 months, and 12 months
Title
Kartus anterior knee pain score
Description
Patients will complete Kartus anterior knee pain score at specific time points to evaluate graft site pain/morbidity throughout treatment
Time Frame
6 weeks, 6 months, 9 months, and 12 months
Title
Graft site morbidity questionnaire
Description
Patients will complete additional survey questions at specific time points to evaluate graft site pain/morbidity throughout treatment
Time Frame
6 weeks, 6 months, 12 months, 24 months
Title
Goniometric measurement: Knee extension and flexion
Description
Patients will undergo goniometric measurement at specific time points to evaluate knee moment throughout treatment.
Time Frame
2 weeks, 6 weeks, 6 months, 9 months and 12 months
Title
Measurement of circumference of the knee
Description
Circumference of the knee will be measured at mid-patella and 15 cm above superior border of the patella. They will be compared with the contralateral knee to compare knee swelling.
Time Frame
2 weeks, 6 weeks, 6 months, 9 months and 12 months
Title
Biodex Isokinetic Measurement
Description
Patients will undergo Biodex Isokinetic measurement at specific time points to muscle strength throughout treatment.
Time Frame
6 months and 12 months
Title
Functional knee tests
Description
Patients will undergo functional knee test (ie one legged jump and crossover jump) at specific time points to evaluate functional knee movement throughout treatment.
Time Frame
6 months, 9 months and 12 months
Title
Lachmans test
Description
Patients will undergo passive accessory stability tests Lachmans test (graded 0,1,2 and 3) at specific time points to evaluate passive knee laxity throughout treatment.
Time Frame
Pre-operative appointment , 6 months, 9 months and 12 months
Title
Pivot shift test
Description
Patients will undergo passive accessory stability tests pivot shift test (graded 0,1,2 and 3) at specific time points to evaluate passive knee laxity throughout treatment.
Time Frame
Pre-operative appointment , 6 months, 9 months and 12 months
Title
Time to Return to Sports Rates
Description
Time to return to sports will be evaluated through Return to Sport surveys at specific time points throughout treatment
Time Frame
6 months, 9 months, 12 months, 18 months, 24 months
Title
Graft failure rate or ACL re-rupture
Description
ACL reconstruction will be evaluated by graft failure rate or ACL re-rupture during a 10 year period
Time Frame
10 years
Title
ACL re-operation
Description
ACL reconstruction will be evaluated by re-operation rate during a 10 year period
Time Frame
10 years
Title
Graft maturity
Description
Graft maturity after ACL reconstruction will be evaluated by MRI at 9 months postoperatively.
Time Frame
9 months
Title
10 year X-Ray
Description
Development of osteoarthritis after ACL reconstruction will be evaluated by plain weight baring X-rays at 10 years.
Time Frame
10 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Primary ACL reconstruction for patients with Tegner score equal or higher than 7 before injury. Exclusion Criteria: Multiligament knee injury Former knee operation Former fracture Inflammatory disease More than one ligamentous injury in the same knee requiring reconstructive surgery Former ACL injury in the contralateral knee Reconstruction of ACL in the contralateral knee during the study follow up period Lack av baseline pre- or postoperative data (KT-1000, KOOS, Lysholm Score, EQ-5D) Any other situation preventing patient from participating in extensive follow up.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anders Stålman, MD,Phd
Phone
0046736665957
Email
anders.stalman@ki.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anders Stålman, MD,PhD
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Mikael Östin, MD
Organizational Affiliation
Capio Artro Clinic AB
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Vasileios Sarakatsianos, MD
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Joanna Kvist, PhD
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Daniel Castellanos, MD
Organizational Affiliation
Örebro University, Sweden
Official's Role
Principal Investigator
Facility Information:
Facility Name
Capio Artro Clinic AB
City
Stockholm
ZIP/Postal Code
11428
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anders Stålman, MD, PhD
First Name & Middle Initial & Last Name & Degree
Vasileios Sarakatsianos, MD
First Name & Middle Initial & Last Name & Degree
Daniel Castellanos, MD
First Name & Middle Initial & Last Name & Degree
Anders Stålman, MD,PhD
First Name & Middle Initial & Last Name & Degree
Mikael Östlin, MD
First Name & Middle Initial & Last Name & Degree
Joanna Kvist, PhD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

SEQUAR SEmitendinosus vs QUadriceps in Anterior Cruciate Ligament Reconstruction

We'll reach out to this number within 24 hrs